Rapid Dose Therapeutics Corp.
RDTCF
$0.08
-$0.01-15.56%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.11M | -3.28M | -3.48M | -3.89M | -4.25M |
| Total Depreciation and Amortization | 326.20K | 270.50K | 208.60K | 174.10K | 267.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.66M | 1.69M | 1.67M | 1.89M | 1.93M |
| Change in Net Operating Assets | 438.90K | 636.60K | 919.90K | 986.40K | 250.90K |
| Cash from Operations | -688.20K | -690.80K | -690.60K | -838.00K | -1.80M |
| Capital Expenditure | -4.00K | -4.00K | -4.00K | -4.00K | -- |
| Sale of Property, Plant, and Equipment | 600.00 | 600.00 | 600.00 | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.40K | -3.40K | -3.40K | -4.00K | -- |
| Total Debt Issued | 734.60K | 374.00K | 122.90K | 33.80K | 157.70K |
| Total Debt Repaid | -100.90K | -283.80K | -383.80K | -412.90K | -412.10K |
| Issuance of Common Stock | 25.40K | 500.40K | 809.40K | 1.39M | 2.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 377.60K | 377.60K | 377.60K | -- | -94.90K |
| Cash from Financing | 743.80K | 697.20K | 666.80K | 740.00K | 1.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -3.00K | -48.80K | -2.70K | -- | -- |
| Net Change in Cash | 49.30K | -45.80K | -29.90K | -101.90K | -92.20K |